Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity.

Site
Frankfurt
Pubmed id
30789735
Authors

Watts E, Heidenreich D, Tucker E, Raab M, Strebhardt K, Chesler L, Knapp S, Bellenie B, Hoelder S

DOI
10.1021/acs.jmedchem.8b01947
Journal
J. Med. Chem.
Publication Date
2019-2-21
Year
2019
N Publication Date
PI authors
Knapp
Validated
Y